LivaNova (LIVN) EBT Growth (1y) (2015 - 2026)
LivaNova (LIVN) EBT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 74.66% |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | -27.02% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 103.34% |
| 10 | LivaNova | 4.37 Bn | 3.83 Bn | 243.75 Mn | 108.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.71% |
| Dec 31, 2025 | -51.07% |
| Sep 30, 2025 | -23.69% |
| Jun 30, 2025 | 54.34% |
| Mar 31, 2025 | -822.94% |
| Dec 31, 2024 | 159.90% |
| Sep 30, 2024 | 2,346.76% |
| Jun 30, 2024 | 308.88% |
| Mar 31, 2024 | -450.12% |
| Dec 31, 2023 | -1,574.76% |
| Sep 30, 2023 | 98.14% |
| Jun 30, 2023 | -72.21% |
| Mar 31, 2023 | 75.40% |
| Dec 31, 2022 | 378.00% |
| Sep 30, 2022 | -155.33% |
| Jun 30, 2022 | 136.17% |
| Mar 31, 2022 | 119.83% |
| Dec 31, 2021 | 99.24% |
| Sep 30, 2021 | -122.06% |
| Jun 30, 2021 | -142.51% |